Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?


Creative Commons License

Capitanio U., Stewart G. D., Klatte T., AKDOĞAN B., Roscigno M., Marszalek M., ...Daha Fazla

EUROPEAN UROLOGY FOCUS, cilt.4, sa.6, ss.972-977, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 4 Sayı: 6
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.euf.2017.02.020
  • Dergi Adı: EUROPEAN UROLOGY FOCUS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.972-977
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background: A non-negligible proportion of individuals diagnosed with cT1 renal cell carcinoma (RCC) are upstaged to pT3a at final pathology. Few data on oncological outcomes for these patients are available to determine whether partial nephrectomy (PN) might jeopardise cancer control.